Back to search

United States· US:60687-931_51911920-109b-a9be-e063-6394a90a733f

Bromocriptine Mesylate

A bromocriptine product containing bromocriptine mesylate, registered in United States by American Health Packaging. The same ATC class is registered in 9 of our 19 countries.

ATC G02CB01Orange BookUS label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedBromocriptine MesylateATCG02CB01REGISTER NO.US:60687-931_51911920…PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Bromocriptine is registered in 9 of 19 countries.

Countries holding a registration under ATC G02CB01 (bromocriptine), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 7 of them publish a price we can compare per daily dose

Bromocriptine · ATC G02CB01

9 / 19 countries

  • Czechiaprice
  • Finlandprice
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of bromocriptine costs, country by country.

Normalised to the WHO defined daily dose (5 mg), the median price runs from $0.54 in Italy to $3.22 in United States — a ×5.9 gap.

  • United States: $3.22 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Bromocriptine · price per daily dose (5 mg)

USD · FX 28 Sept 2026

  • US United States$3.22 (acquisition cost)
  • CH Switzerland$2.09
  • IT Italy$0.54
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
Bromocriptine Mesylate
Manufacturer
American Health Packaging
Country
United States (US)
ATC code
G02CB01
ATC class
Bromocriptine
Defined daily dose
5 mg, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 12, 2026

Packs & prices · 1

  • ndc11
    6068793121
    30 BLISTER PACK in 1 CARTON (60687-931-21) / 1 TABLET in 1 BLISTER PACK (60687-931-11)

Regulatory notes

UNII (FDA substance ID)
FFP983J3OD
BROMOCRIPTINE MESYLATE
RxCUI 142426
Orange Book
N017962
ABAB
DailyMed SPL labels
1 version tracked

Interactions

92 interactions on record for bromocriptine.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Bromocriptine · interactions on record

92 records

  • 3 severe
  • 87 moderate
  • 2 minor

Most severe, free to view

  • IsomethepteneA03AX10severe
  • LorcaserinA08AA11severe
  • PhenylpropanolaminA08AA13severe
  • LansoprazoleA02BC03moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Bromocriptine in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All bromocriptine products

Authorised across Europe · EMA

The same active substance is authorised in 22 EEA countries. Names it is sold under:

  • Belgium · Parlodel
  • Bulgaria · Бромокриптин Медокеми
  • Cyprus · Medocriptine, Pirodal
  • Czechia · Medocriptine
  • Germany · Pravidel
  • Estonia · Bromocriptin Richter
  • Spain · Parlodel
  • France · Parlodel
  • United Kingdom (Northern Ireland) · Bromocriptine, Bromocriptine Brown & Burk Uk
  • Hungary · Bromocriptin Richter
  • Italy · Parlodel
  • Lithuania · Bromocriptin Richter
  • Luxembourg · Pravidel
  • Latvia · Bromocriptin Richter
  • Malta · Medocriptine
  • Netherlands · Parlodel
  • Norway · Parlodel
  • Poland · Bromocorn
  • Portugal · Bromocriptina Generis, Parlodel
  • Romania · Brocriptin
  • Sweden · Pravidel
  • Slovakia · Medocriptine

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/0e8c0da0-01d7-47bf-bf12-dcce6dc21e0e
GET /v1/drugs/0e8c0da0-01d7-47bf-bf12-dcce6dc21e0e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unii": {
    "unii": "FFP983J3OD",
    "rxcui": "142426",
    "inchikey": "NOJMTMIRQRDZMT-GSPXQYRGSA-N",
    "display_name": "BROMOCRIPTINE MESYLATE",
    "substance_type": "chemical",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "ORAL",
  "livertox": {
    "summary": null,
    "livertox_id": null,
    "hepatotoxicity_score": 4
  },
  "spl_meta": {
    "ddd292a5-72af-448f-8b88-cc4fd99ec783": {
      "match": "brand_token",
      "title": "BROMOCRIPTINE MESYLATE TABLET [AMERICAN HEALTH PACKAGING]",
      "spl_version": "1",
      "published_date": "2026-05-13"
    }
  },
  "productid": "60687-931_51911920-109b-a9be-e063-6394a90a733f",
  "productndc": "60687-931",
  "dosage_form": "TABLET",
  "orange_book": {
    "appl_no": "017962",
    "products": [
      {
        "rs": false,
        "rld": true,
        "te_code": "AB",
        "strength": "EQ 2.5MG BASE",
        "product_no": "001",
        "approval_date": "Approved Prior to Jan 1, 1982"
      },
      {
        "rs": false,
        "rld": true,
        "te_code": "AB",
        "strength": "EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**",
        "product_no": "002",
        "approval_date": "Mar 1, 1982"
      }
    ],
    "appl_type": "N"
  },
  "dea_schedule": null,
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "BROMOCRIPTINE MESYLATE",
  "proprietary_name": "Bromocriptine Mesylate",
  "active_ingred_unit": "mg/1",
  "application_number": "NDA017962",
  "marketing_category": "NDA",
  "nonproprietary_name": "Bromocriptine Mesylate",
  "start_marketing_date": "20260501",
  "active_numerator_strength": "2.5"
}

See everything about bromocriptine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.